A clinical-stage biotech company developing antibody therapies targeting immune-related diseases, especially inflammatory bowel disease (IBD).

The US Food and Drug Administration (FDA) has approved an expanded indication of the intravenous (IV) formulation of South ...

Germany’s Bayer experienced a nightmare day’s trading Wednesday, with shares in the life sciences company more than 8% lower ...

Biologics-focused contract manufacturing and research organization Abenza announced that Geoffrey Glass has been appointed ...

Denmark’s Novo Nordisk saw its shares fall 4.8% to 291.20 kroner by early afternoon, after it posted financials results for ...

Pharmaceutical regulation is undergoing its biggest shake-up in decades. On both sides of the Atlantic, policymakers are ...

US specialty pharma business SERB Pharmaceuticals is acquiring Y-mAbs Therapeutics (Nasdaq: YMAB) in a $412 million all-cash ...

Danish diabetes and obesity giant Novo Nordisk has announced the filing of 14 new lawsuits to safeguard patients from unsafe ...

Teva Pharmaceutical has received a green light from the US regulator for its biologic Ajovy (fremanezumab) to be used for ...

Further evidence that US Department of Health and Human Services (HHS) secretary Robert F Kennedy Junior (RFK Jr) is willing ...

Japanese drugmaker Nxera Pharma has unveiled a slate of new programs targeting obesity and related metabolic diseases, ...

The Russian government plans to increase procurements of drugs against hepatitis C due to a significant increase in the ...